T Cell Reagent Research for the Study of Allergic Diseases (U19)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support studies to understand the role of allergen epitope-specific T-cell responses in the pathogenesis and treatment of allergic diseases by utilizing allergen epitope-specific reagents. The FOA will also support novel T-cell epitope identification, characterization and validation of important food allergens and aeroallergens that have not been previously studied.

Only 1 application per institution is allowed.


  • Duke Internal: December 1, 2016
  • Letter of Intent Due Date(s): February 3, 2017
  • Application Due Date(s): March 3, 2017

​RFA-AI-16-027 Expiration Date March 4, 2017

Agency Website



Amount Description

Application budgets are limited to $600,000 direct cost per year and need to reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period. The maximum project period is 5 years. 

Funding Type





Medical - Basic Science
Medical - Clinical Science

Internal Nomination

Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials as one PDF.

* A letter of support from dean or chair - 1 to 1.5 pages
* Project summary - 2 to 4 pages
* CV or Biosketch of project leader

Applicants will need to submit internal materials through My Research Proposal.(Code ILN) https://www.grantinterface.com/Common/LogOn.aspx?eqs=ApVvmgXCk2Uj7AzWyDEJKQ2

Instructions for setting up your account and uploading internal applications can be found here: https://ors.duke.edu/sites/default/files/Applicant Instructions_FINAL.pdf

Internal Deadline

December 1, 2016

External Deadline

March 3, 2017